[Skip to content]

Prostate Cancer Research

Prostate cancer is the most common male cancer in the UK. Almost 41,000* men are diagnosed with the disease each year.

Our knowledge of the disease is increasing and scientists at The Institute of Cancer Research (ICR) have made great progress. As the ICR's dedicated male cancer appeal, Everyman is helping to fund a range of prostate cancer research including:

Abiraterone, a new treatment for advanced prostate cancer

Active Surveillance - potential alternative to radical prostate cancer treatment

Intensity Modulated Therapy

Environmental factors in prostate cancer

Genetic causes of prostate cancer

PARP Inhibitors

Role of stem cells in prostate cancer progression

Tiger Pussycat Test - Prostate cancer aggressiveness test

 

 

 

 

 

 

 

*Source: Cancer Research UK

Urchin Tracking Gif